Merck & Co., Inc. (MRK) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Merck & Co., Inc. (MRK) short-term stock forecast for year 2025, month by month, and long-term MRK price prediction for years 2025 to 2050. Check MRK historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest MRK news and headlines.
1 Month Prediction
$226.90 [158.22%]
3 Month Prediction
$216.52 [146.41%]
6 Month Prediction
$210.95 [140.07%]
1 Year Prediction
$235.33 [167.82%]
3 Year Prediction
$242.04 [175.46%]
5 Year Prediction
$245.47 [179.36%]
About Merck & Co., Inc.
Merck & Co., Inc., known as MSD outside the United States and Canada, is a leading American multinational pharmaceutical company that develops prescription medicines, vaccines, biologic therapies, and animal health products.
The company provides treatments for various conditions such as cancer, cardiovascular diseases, diabetes, immune disorders, and infectious diseases. Its notable products include the cancer immunotherapy Keytruda, the HPV vaccine Gardasil, and diabetes medications like Januvia.
The company was founded in 1891 by George Merck, and It has its headquarters in Rahway, New Jersey.
Merck & Co., Inc. (MRK) Historical Performance
IPO Date
Merck & Co., Inc. (NYSE:MRK) went public on 02 January, 1970.
Change
Since inception, MRK has increased by 11,959.90%. In the last 5 years, MRK has risen from $64.94 to $87.87, a massive 35.32% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $127.34 and a low of $60.82.
52 Week Range
$81.04
$134.63
The current price $87.87 is near the 52-week low, which means that the stock is underbought.
MRK Stock Price History
Based on MRK stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the MRK stock has risen from $62.15 - $70.34 to $87.87 - $97.97, which is up 36.61%. Currently, the stock follows upward trend.
Here, we have calculated stock range of MRK, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $62.15 - $70.34 | $65.87 | -2.65 | 1 Year Change |
| 2021 | $60.82 - $79.34 | $67.13 | -0.79 | 2 Year Change |
| 2022 | $69.66 - $103.48 | $84.15 | 24.37 | 3 Year Change |
| 2023 | $97.97 - $109.16 | $102.28 | 51.16 | 4 Year Change |
| 2024 | $97.84 - $127.34 | $114.16 | 68.72 | 5 Year Change |
| 2025 | $87.87 - $97.97 | $92.43 | 36.61 | 6 Year Change |
MRK Price Performance
6-Month Performance
MRK stock dropped by 12.69% in the last six months.
1-Year Performance
The stock has trended downwards by 29.98% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 7.96%.
5-Year Performance
In the last 5 years, the stock has gone up by 35.32%.
According to Merck & Co., Inc.'s historical data, below graph gives us the exact picture of how the MRK stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 3 years and a decline in 2 years.
2020
7.30% ↓
2021
1.59% ↑
2022
49.85% ↑
2023
0.95% ↑
2024
6.33% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Merck & Co., Inc. (MRK) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $15.62 B (Q4)
Revenue for Q4 ending 31st December, 2024 decreased 6.20% compared to Q3 ending 30th September, 2024.
Annual Revenue: $64.17 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
Market Capitalization
Merck & Co., Inc. has a market capitalization of $221.96B, which places MRK in the mega-cap category.
Fundamental Analysis
EPS: $1.48 (Q4), $nan (1Y)
EPS increased 18.77% since last quarter, and decreased nan% since last year.
Net Income: $3.74 B (Q4), $17.12 B (1Y)
Net Income increased 18.56% since last quarter, and increased 4,589.59% since last year.
Free Cash Flow: $2.51 B (Q4), $18.10 B (1Y)
Free Cash Flow decreased 70.46% since last quarter, and increased 97.92% since last year.
Net Profit Margin: 23.96% (Q4), 26.68% (1Y)
Net Profit Margin increased 26.40% since last quarter, and increased 4,589.59% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for MRK stock. These indicators help you understand Merck & Co., Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for MRK stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $92.68 |
| SMA50 | $92.30 |
| SMA200 | $105.85 |
| RSI | 34.67 |
| Beta | 0.36 |
SMA20 > Current Price
This signals MRK stock is in short-term bearish momentum.
SMA50 > Current Price
This signals MRK stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals MRK stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for MRK stock is Bearish. Out of all indicators, 2 indicates bullish signals, 4 signals bearish trends and 3 gives neutral trends. The MRK stock forecast was last updated on 26 March, 2025.
Merck & Co., Inc. (MRK) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $206.66 by the end of 2025, and can reach around $199.94 to $231.71 in 2026. And, the long-term forecast suggests that the stock may further jump to $243.59 - $250.29 in 2028, and $251.84 - $235.96 by 2031. So, the MRK stock shows a strong upward trend in the next several years.
Short-term MRK Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $226.90 | 158.22% |
| 2025-05 | $220.33 | 150.75% |
| 2025-06 | $216.52 | 146.41% |
| 2025-07 | $206.24 | 134.71% |
| 2025-08 | $212.71 | 142.07% |
| 2025-09 | $210.95 | 140.07% |
| 2025-10 | $199.22 | 126.72% |
| 2025-11 | $199.29 | 126.8% |
| 2025-12 | $206.66 | 135.19% |
In 2025, the MRK stock price is expected to fluctuate between $199.22 and $226.9. According to the monthly forecast, the stock could rise to $206.66 by December 2024. If compared to the MRK's current price, the stock could gain 135.19% by the end of this year.
Long-term MRK Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $199.94 | $231.08 | $231.71 | 163.7% |
| 2027 | $215.52 | $216.51 | $249.07 | 183.45% |
| 2028 | $243.59 | $217.34 | $250.29 | 184.84% |
| 2029 | $243.10 | $226.21 | $221.32 | 151.87% |
| 2030 | $214.96 | $228.07 | $218.38 | 148.53% |
| 2031 | $251.84 | $255.02 | $235.96 | 168.53% |
| 2032 | $212.27 | $240.57 | $235.51 | 168.02% |
| 2033 | $242.96 | $238.84 | $239.38 | 172.43% |
| 2034 | $239.41 | $257.15 | $232.72 | 164.85% |
| 2035 | $236.77 | $245.96 | $241.92 | 175.32% |
| 2036 | $238.05 | $263.36 | $238.40 | 171.31% |
| 2037 | $232.11 | $257.57 | $264.48 | 200.99% |
| 2038 | $224.90 | $233.77 | $233.55 | 165.79% |
| 2039 | $241.61 | $245.97 | $247.05 | 181.15% |
| 2040 | $268.74 | $281.74 | $250.93 | 185.57% |
| 2041 | $246.81 | $249.83 | $243.43 | 177.03% |
| 2042 | $250.58 | $260.25 | $249.08 | 183.46% |
| 2043 | $237.49 | $245.14 | $236.92 | 169.63% |
| 2044 | $235.54 | $222.48 | $261.94 | 198.1% |
| 2045 | $259.43 | $280.87 | $268.83 | 205.94% |
| 2046 | $258.19 | $270.37 | $268.41 | 205.46% |
| 2047 | $228.65 | $269.84 | $254.44 | 189.56% |
| 2048 | $256.01 | $265.17 | $241.22 | 174.52% |
| 2049 | $251.13 | $243.80 | $279.81 | 218.44% |
| 2050 | $279.09 | $287.86 | $275.68 | 213.74% |
| 2051 | $246.14 | $275.92 | $254.51 | 189.64% |
Merck & Co., Inc. (MRK) Stock Price Prediction & Forecast 2025
At the start of 2025, the MRK stock was at $97.97. Today, it is trading at $87.87, which is -10.31% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $206.66 by December 2025 with a 135.19% change.
Merck & Co., Inc. (MRK) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the MRK stock. During this period, the MRK's price is forecasted to shift from $199.94 to $218.38, which is 9.22% gain.
In 2026, the stock would possibly open at $199.94, escalates to $231.08 by mid-year, and wraps up at $231.71, reflecting a 163.69% increase from today's price. Further moving to 2030, the stock can kick off the year at $214.96, soar to $228.07 by mid-year, and finish at $218.38, which is 148.53% change from current price.
Merck & Co., Inc. (MRK) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $251.84 to $250.93, which is down 168.53%
In 2031, we can expect MRK to fluctuate between $235.96 and $251.84, a shift indicating a 168.53% gain by year-end compared to current price. And Until 2040, MRK can likely vary from $250.93 to $268.74. By the end of 2040, the stock could record a 185.57% rise from today's stock price.
Merck & Co., Inc. (MRK) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the MRK stock can see an an upturn from $246.81 to $275.68 in this period. In 2041, the stock can experience a high of $249.83 by mid-year, closing the year at $243.43. This results in a 184.32% increase from today.
Moving towards the end of 2050, MRK is projected to open the year at $279.09. The stock may peak to $287.86 during mid-year and finish the year at $275.68. Compared to the stock's current price, this translates to an overall gain of 213.74% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
MRK Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | - | $59.28 | -0.56% ▼ | $58.39 ▲ |
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| NVO | Novo Nordisk A/S | - | $73.60 | -18.81% ▼ | $247.89 ▲ |
| LLY | Eli Lilly and Company | - | $738.21 | -10.62% ▼ | $130.57 ▲ |
| JNJ | Johnson & Johnson | - | $163.63 | -0.05% ▼ | $80.87 ▲ |
Last updated Mar 26 at 12:07 PM
MRK : Buy, Sell Or Hold?
Analyst Ratings
Based on 24 analysts, 3 rated as a strong buy, 11 recommended a buy, 10 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 27 analysts, 5 analysts gave a strong buy rating, 15 a buy rating, 7 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for MRK stock is Buy.
Expert Analysis
According to MRK short-term and long-term forecast, Merck & Co., Inc. shares are projected to go up by 213.74%, and reach a value of $275.68 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 28.571428571428573, which signals Fear. Also, MRK has recorded 12/30 green days, which reflects a 54.54545454545454% positivity rate with a price volatility of 0.02%.
Plus, Price-to-Earnings (P/E) ratio of 13.037093 suggests that MRK stock is overvalued. So, Based on MRK prediction and analysis, it may be the best time to hold MRK stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "MRK” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.